Psychoactive drugs alter brain function by changing how nerve cells communicate with each other. They do this by mimicking, blocking, or amplifying the chemical signals that neurons use to pass messages across tiny gaps called synapses. The specific effects depend on which signaling system a drug targets, but nearly all psychoactive substances share one thing in common: they have to cross a highly selective barrier between the bloodstream and the brain before they can do anything at all.
How Drugs Get Into the Brain
The brain is protected by a tightly sealed layer of cells called the blood-brain barrier, which filters out most substances circulating in the blood. Only certain molecules can pass through, primarily those that dissolve easily in fat (lipid-soluble molecules), along with water and specific gases. Psychoactive drugs are effective precisely because their chemical structure lets them slip through this barrier.
How quickly a drug crosses that barrier shapes how intense and addictive it feels. Heroin, for example, is chemically modified morphine with two extra molecular groups that make it roughly 100 times faster at entering the brain than morphine itself, which likely contributes to its higher addictive potential. Nicotine reaches the brain within 10 to 20 seconds of inhalation because of its fat-soluble structure. Methamphetamine crosses rapidly for the same reason. The brain also has active pump systems that push certain substances back out. Morphine, for instance, is partially expelled by a protein pump that works against it, which is one reason heroin (which bypasses that pump more easily) produces a stronger initial rush.
Stimulants and the Dopamine Flood
Stimulants like cocaine, amphetamines, and methamphetamine all increase dopamine levels in the synapse, but they do it in different ways. Cocaine blocks the recycling mechanism that normally pulls dopamine back into the sending neuron after it delivers its signal. This doesn’t create extra dopamine. It simply prevents the existing dopamine from being cleared away, so it keeps activating the receiving neuron for longer than it normally would.
Amphetamines go a step further. They block reuptake like cocaine does, but they also force the sending neuron to release more dopamine into the synapse in the first place. The result is a larger, longer surge of dopamine signaling. This is why amphetamines tend to produce more sustained effects than cocaine, which wears off faster as the body metabolizes it.
The Brain’s Reward Circuit
The reason so many psychoactive drugs produce euphoria, and the reason that euphoria can become compulsive, traces back to a specific circuit deep in the brain. A cluster of neurons in the midbrain sends dopamine-releasing projections to a region called the nucleus accumbens, which is central to how the brain assigns value and motivation to experiences. This pathway evolved to reinforce survival behaviors like eating and social bonding.
Opioids hijack this circuit in a particularly effective way. When morphine or heroin activates opioid receptors in the midbrain, it silences a set of inhibitory neurons that normally keep dopamine release in check. With those brakes removed, dopamine floods into the nucleus accumbens. The brain registers this as an intensely rewarding experience, encoding a powerful memory that drives future drug-seeking behavior. This same reward circuit is activated, to varying degrees, by virtually every class of addictive substance.
Depressants and Inhibitory Signaling
Alcohol, benzodiazepines, and barbiturates work by enhancing the brain’s primary braking system. Neurons communicate using both excitatory signals (which encourage the next neuron to fire) and inhibitory signals (which discourage it). The main inhibitory chemical messenger is called GABA. When GABA binds to its receptor on a neuron, it makes that neuron less likely to fire, slowing down brain activity.
Depressant drugs amplify this effect. They bind to GABA receptors and make them more responsive to GABA, increasing inhibitory signaling across wide areas of the brain. This produces sedation, reduced anxiety, muscle relaxation, and impaired coordination. At high doses, the suppression of brain activity can slow breathing and heart rate to dangerous levels, which is why depressant overdoses are life-threatening and why combining alcohol with benzodiazepines is especially risky.
How Psychedelics Reshape Perception
Classic psychedelics like LSD, psilocybin (the active compound in magic mushrooms), and mescaline all activate a specific type of serotonin receptor concentrated in the cortex, the brain’s outer layer responsible for perception, thought, and sensory processing. What makes psychedelics unique is not just that they activate this receptor, but how they activate it. Closely related compounds that stimulate the same receptor, like a drug called lisuride, don’t produce hallucinations at all.
The difference comes down to what happens inside the cell after the receptor is activated. Psychedelics trigger a distinct cascade of intracellular signals involving specific protein pathways that non-hallucinogenic compounds don’t engage. Research using genetically modified mice showed that serotonin receptors on cortical neurons alone are sufficient to produce the full behavioral response to psychedelics. In other words, the hallucinogenic experience originates specifically in the cortex, where these drugs disrupt the brain’s normal filtering and interpretation of sensory information.
Dissociatives and Blocked Communication
Dissociative drugs like ketamine and PCP work through a fundamentally different mechanism. Rather than amplifying a signal, they block one. Their target is the NMDA receptor, which responds to glutamate, the brain’s primary excitatory messenger. NMDA receptors play a key role in learning, memory, and the integration of sensory information with your sense of self.
Ketamine works through what’s called open channel block. It doesn’t bind to the receptor when it’s closed. Instead, it waits for the receptor’s ion channel to open normally, then slips inside and physically plugs it, preventing charged particles from flowing through. Once lodged inside, it can remain trapped even after the channel closes. This selective blockade disrupts the normal flow of excitatory communication across the brain, producing the characteristic feeling of detachment from your body and surroundings.
Cannabis and Retrograde Signaling
Cannabis works through a system your brain already uses to regulate itself. The brain produces its own cannabinoid-like molecules (endocannabinoids) that act as a feedback mechanism: when a receiving neuron is being overstimulated, it releases endocannabinoids that travel backward across the synapse to tell the sending neuron to quiet down. THC, the primary psychoactive compound in cannabis, mimics these molecules by binding to CB1 receptors.
CB1 receptors are among the most abundant receptors in the entire brain, found at especially high concentrations in areas responsible for higher thinking (the cortex), memory formation (the hippocampus), movement coordination (the basal ganglia and cerebellum), and basic functions (the brainstem). These receptors sit on the sending side of the synapse, where they reduce the release of other neurotransmitters. This is why cannabis affects such a wide range of functions simultaneously: memory, coordination, mood, appetite, and pain perception all have heavy CB1 receptor involvement.
How the Brain Adapts Over Time
With repeated drug exposure, the brain fights back to restore balance through a process that underlies tolerance. One key mechanism is receptor downregulation, where the brain reduces either the number of receptors available on cell surfaces or their sensitivity. After chronic activation, receptors can be chemically modified, pulled inside the cell, or simply become less responsive. The practical result is that the same dose produces a weaker effect, pushing users to take more to achieve the original experience.
This adaptation also explains withdrawal. Once the brain has recalibrated its signaling to account for a drug’s constant presence, removing the drug leaves the system unbalanced in the opposite direction. A brain accustomed to amplified GABA signaling from alcohol, for instance, becomes hyperexcitable without it, producing anxiety, tremors, and in severe cases, seizures.
Long-Term Structural Changes
Psychoactive drugs don’t just alter chemistry temporarily. They physically reshape the brain’s wiring. In animal studies, rats that self-administered cocaine developed increased density of dendritic spines (the tiny protrusions on neurons where synaptic connections form) in the nucleus accumbens. These structural changes persisted even during abstinence and are thought to contribute to long-term vulnerability to relapse. Chronic opioid exposure produced the opposite effect in the midbrain reward area, reducing dendritic spines on neurons there.
The prefrontal cortex, the region responsible for decision-making, impulse control, emotional regulation, and flexible thinking, is particularly vulnerable to drug-related disruption. Neuroimaging research has documented a wide pattern of prefrontal impairment in people with substance use disorders. Self-control and the ability to inhibit impulsive responses become compromised. Emotional regulation weakens, leading to heightened stress reactivity and difficulty managing negative feelings. Motivation narrows: the drive to obtain drugs intensifies while motivation for other goals decreases. Attention becomes biased toward drug-related cues at the expense of other information. Decision-making shifts toward immediate rewards, with reduced ability to weigh future consequences.
These prefrontal changes help explain why addiction looks from the outside like a failure of willpower. The very brain systems responsible for exercising self-control and making sound choices are the ones being structurally and functionally degraded by chronic drug use, creating a cycle that becomes progressively harder to break without intervention.